We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$59.6B
AUM Growth
+$1.09B
Cap. Flow
-$2.18B
Cap. Flow %
-3.66%
Top 10 Hldgs %
10.82%
Holding
3,128
New
198
Increased
1,235
Reduced
1,344
Closed
181

Sector Composition

Rank Sector Weight
1 Financials 19.84%
2 Technology 12.25%
3 Healthcare 11.36%
4 Consumer Discretionary 9.81%
5 Industrials 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BV
2676
DELISTED
Bazaarvoice, Inc.
BV
$96K ﹤0.01%
17,643
-1,221,393
-99% -$6.16M
DO
2677
DELISTED
Diamond Offshore Drilling
DO
$96K ﹤0.01%
5,200
-45,684
-90% -$743K
ARDX icon
2678
Ardelyx
ARDX
$988M
$95K ﹤0.01%
+14,200
New +$84.1K
GIFI
2679
DELISTED
Gulf Island Fabrication
GIFI
$95K ﹤0.01%
+7,100
New +$89.8K
GOOD
2680
Gladstone Commercial Corp
GOOD
$627M
$95K ﹤0.01%
4,485
-19,833
-82% -$439K
LYTS icon
2681
LSI Industries
LYTS
$924M
$95K ﹤0.01%
13,600
-400
-3% -$2.7K
ITCI
2682
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$94K ﹤0.01%
6,200
-200
-3% -$3.09K
TCON
2683
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$93K ﹤0.01%
+146
New +$88.1K
RAVN
2684
DELISTED
Raven Industries Inc
RAVN
$93K ﹤0.01%
2,700
-400
-13% -$13.6K
KVHI icon
2685
KVH Industries
KVHI
$157M
$92K ﹤0.01%
8,811
LCTX icon
2686
Lineage Cell Therapeutics
LCTX
$274M
$92K ﹤0.01%
47,094
-12,801
-21% -$28K
INFI
2687
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$91K ﹤0.01%
40,900
-1,800
-4% -$3.73K
ALEX
2688
DELISTED
Alexander & Baldwin
ALEX
$89K ﹤0.01%
3,223
-4,063
-56% -$159K
LQDT icon
2689
Liquidity Services
LQDT
$1.31B
$89K ﹤0.01%
18,510
-23,290
-56% -$127K
UEIC icon
2690
Universal Electronics
UEIC
$60.1M
$89K ﹤0.01%
1,886
-23,500
-93% -$1.3M
WEYS icon
2691
Weyco Group
WEYS
$440M
$89K ﹤0.01%
+3,191
New +$89.7K
VNDA icon
2692
Vanda Pharmaceuticals
VNDA
$302M
$88K ﹤0.01%
5,753
-8,873
-61% -$132K
BTU.PR
2693
DELISTED
Peabody Energy Corporation Series A Convertible Preferred Stock
BTU.PR
$88K ﹤0.01%
1,185
+48
+4% +$2.99K
ZTO icon
2694
ZTO Express
ZTO
$17.9B
$87K ﹤0.01%
5,470
TTPH
2695
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$87K ﹤0.01%
675
-25
-4% -$3.2K
CSR
2696
Centerspace
CSR
$952M
$86K ﹤0.01%
+1,500
New +$89.1K
CTIC
2697
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$86K ﹤0.01%
+32,318
New +$94.7K
HBIO icon
2698
Harvard Bioscience
HBIO
$29.2M
$85K ﹤0.01%
2,616
BLCM
2699
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$85K ﹤0.01%
+1,010
New +$99K
HMHC
2700
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$85K ﹤0.01%
+9,100
New +$90.8K

Similar funds

Russell Investments Group's Q4 2017 Portfolio in Review

As of Q4 2017, Russell Investments Group held 3,128 positions worth $59.6B, up 1.9% from $58.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Russell Investments Group withdrew a net $2.18B in Q4 2017, closing 181 positions and reducing 1,344 holdings. Its most notable exit was Embraer S.A. ADS, an estimated $53.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Russell Investments Group opened a new position in Cannae Holdings worth $15.6M.

  • Russell Investments Group's largest Q4 2017 buy was Cannae Holdings: 903,862 shares worth $15.6M.
  • Russell Investments Group added most to Exelon in Q4 2017, an estimated $87.9M increase.
  • Russell Investments Group's biggest Q4 2017 reduction was CNH Industrial, cutting an estimated $132M.
  • Russell Investments Group fully exited Embraer S.A. ADS in Q4 2017, selling an estimated $53.5M.
  • Russell Investments Group's ten largest holdings make up 11% of its $59.6B portfolio in Q4 2017.
  • Russell Investments Group opened 198 new positions and closed 181 in Q4 2017.
  • Russell Investments Group's portfolio value rose 1.9% quarter-over-quarter to $59.6B.

Based on Russell Investments Group's 13F filing for Q4 2017, filed 6 Feb 2018.